Henry Schein, Inc. (HSIC) Stock Analysis

Company Overview

Henry Schein, Inc. operates as a global provider of healthcare products and services specifically tailored for office-based dental and medical practitioners worldwide. The company organizes its operations into three primary segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. As a leading entity within the Healthcare sector and the Medical Distribution industry, the firm facilitates the flow of essential medical supplies and equipment to practitioners globally. The company's financial scale is substantial, with a market capitalization of $8.56B and annual revenue reaching $13.18B, supported by a workforce of 25,000 employees. These valuation and revenue figures indicate that Henry Schein holds a significant position in its industry, reflecting the high demand for its distribution network and specialized technology solutions.

Financial Health

The company reported revenue of $13.18B for the trailing twelve months, generating a net income of $398.00M and an EBITDA of $1.02B. The substantial gap between the total revenue of $13.18B and the net income of $398.00M reveals a cost structure heavily influenced by operating expenses, resulting in a profit margin of 3.0%. Free cash flow stands at $383.00M, which demonstrates that the company generates significant cash after capital expenditures, providing financial flexibility for operational investments or debt servicing. The gross margin is 31.1%, indicating strong pricing power or efficient supply chain management relative to the cost of goods sold. The operating margin of 5.3% suggests that after covering operating expenses, the company retains a modest portion of revenue as operating profit before interest and taxes. In contrast, the profit margin of 3.0% reflects the impact of interest, taxes, and other non-operating expenses on the final bottom line. On the balance sheet, cash holdings of $156.00M are significantly lower than total debt of $3.44B, while the debt-to-equity ratio is 71.74%, indicating a leveraged balance sheet rather than a conservative one. The current ratio is 1.38, which indicates that the company possesses sufficient current assets to cover its short-term liabilities with a buffer of 38% above the 1:1 threshold. Return on Equity is 8.7% and Return on Assets is 4.3%, metrics that reveal how effectively management utilizes shareholder equity and total assets to generate profits.

Valuation Assessment

The trailing twelve-month P/E ratio is 22.23, while the forward P/E is 12.44, implying that the market expects earnings to grow significantly in the future to justify the lower forward multiple. The price-to-book ratio stands at 2.59, indicating that the market values the company at a premium of 159% over its net asset book value. Alternative valuation metrics include a price-to-sales ratio of 0.65 and an EV/EBITDA of 12.87, suggesting the stock is priced at 65% of its sales revenue and that enterprise value relative to earnings before interest, taxes, depreciation, and amortization is moderate. The 52-week high is $89.29 and the 52-week low is $60.56, meaning the current trading price sits below the annual peak but above the annual floor. The beta value is 0.85, which indicates that the stock's price volatility is lower than the broader market, moving only 85% as much as the overall market index.

Growth & Income

Revenue growth year-over-year is 7.7%, while earnings growth year-over-year is 13.6%, demonstrating that earnings are growing faster than revenue. This divergence implies that the company is improving its profitability through margin expansion or cost efficiencies rather than solely relying on top-line volume increases. Regarding income distribution, the dividend yield is N/A and the payout ratio is 0.0%, indicating that the company does not currently pay dividends. Instead, the firm reinvests its earnings back into the business to fund growth initiatives, acquisitions, or technology development rather than returning capital to shareholders via dividends. The overall growth and income profile is characterized by robust earnings expansion and a retention strategy typical of companies prioritizing capital allocation for long-term operational scaling over immediate shareholder payouts.